RxDoctor Payments Data

James Chen, MD

Adult Reconstructive Orthopaedic Surgery · Mission Viejo, CANPI 1104210152

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 77.8% of it on its own, with 15 other manufacturers making up the rest.

$496,730in general payments, 2019–2025

Across 626 payments — averaging $793.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$387K
  • Orthalign Inc$107K
  • Stryker$1K
  • Medical Device Business Services, Inc.$348
  • Smith+Nephew$274
  • Engage Uni, LLC$201
  • plus $807 from 10 others
$5,000in research payments, 2019–2025

Across 13 payments — averaging $384.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Canary Medical USA LLC$5K

What the payments were for

  • Consulting fees$246,28050%
  • Travel & lodging$54,27011%
  • Food & beverage$10,7872%
  • Education$185,39337%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$496,730 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$544,552
Medicare patients
633
Services billed
7,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$18,402
Oxycodone Hcl100$809
Meloxicam247$584
Celecoxib20$580
Cefadroxil57$287
Tramadol Hcl81$260
Methocarbamol57$228
Cephalexin15$194
Gabapentin34$138
Amoxicillin81$123
Ondansetron OdtOndansetron20$86

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Mission Viejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →